ArticleCureus2025
Cefadroxil-Induced Radiation Recall Dermatitis: A Case Report and Review of the Literature.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Radiation recall dermatitis (RRD) is a rare phenomenon. There are a few reports in the literature reporting RRD triggered by quinolone administration after external beam radiation therapy (EBRT). We present an unusual case of RRD induced by cefadroxil, which occurred months after completion of EBRT. A patient underwent accelerated partial breast irradiation (APBI) to the right breast, which she finished without any side effects to the skin. She then underwent a left hip replacement and was placed on an antibiotic called cefadroxil 500 mg BID (twice a day), which correlated with a sudden redness in the right breast. The antibiotic was stopped, and her affected breast was treated with clobetasol cream 0.05%, and the patient's RRD resolved. We review literature emphasizing cefadroxil antibiotic as a causative agent of RRD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.